Literature DB >> 28670664

Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Ryan C Lynch1, Dita Gratzinger2, Ranjana H Advani3,4.   

Abstract

OPINION STATEMENT: The 2016 revision of the WHO classification of lymphoid neoplasms includes new entities along with a clearer definition of provisional and definitive subtypes based on better understanding of the molecular drivers of lymphomas. These changes impact current treatment paradigms and provide a framework for future clinical trials. Additionally, this update recognizes several premalignant or predominantly indolent entities and underscores the importance of avoiding unnecessarily aggressive treatment in the latter subsets.

Entities:  

Keywords:  ALK-negative anaplastic large cell lymphoma (ALCL); BCL6 translocations; Burkitt lymphoma; Chronic lymphocytic leukemia (CLL); Diffuse large B cell lymphoma (DLBCL); Double hit lymphoma; Follicular lymphoma; High grade B cell lymphoma NOS; Lymphoplasmacytic lymphoma; Mantle cell lymphoma; Non-Hodgkin lymphoma; Waldenström macroglobulinemia

Mesh：

Substances：

Year:  2017        PMID： 28670664     DOI： 10.1007/s11864-017-0483-z

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN： 1534-6277


  147 in total

1.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

2.  Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?

Authors:  Tony Petrella; Eve Maubec; Pascale Cornillet-Lefebvre; Rein Willemze; Michel Pluot; Anne Durlach; Eduardo Marinho; Jean-Luc Benhamou; Patty Jansen; Alistair Robson; Florent Grange
Journal:  Am J Surg Pathol       Date:  2007-12       Impact factor: 6.394

3.  Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.

Authors:  Joel F Gradowski; Rachel L Sargent; Fiona E Craig; Kathleen Cieply; Kim Fuhrer; Carol Sherer; Steven H Swerdlow
Journal:  Am J Clin Pathol       Date:  2012-07       Impact factor: 2.493

4.  Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies.

Authors:  Raju K Pillai; Urvashi Surti; Steven H Swerdlow
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

5.  Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.

Authors:  Wyndham H Wilson; Ryan M Young; Roland Schmitz; Yandan Yang; Stefania Pittaluga; George Wright; Chih-Jian Lih; P Mickey Williams; Arthur L Shaffer; John Gerecitano; Sven de Vos; Andre Goy; Vaishalee P Kenkre; Paul M Barr; Kristie A Blum; Andrei Shustov; Ranjana Advani; Nathan H Fowler; Julie M Vose; Rebecca L Elstrom; Thomas M Habermann; Jacqueline C Barrientos; Jesse McGreivy; Maria Fardis; Betty Y Chang; Fong Clow; Brian Munneke; Davina Moussa; Darrin M Beaupre; Louis M Staudt
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

6.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

7.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

8.  Randomized Phase 2 Open-Label Study of R-CHOP ± Bortezomib in Patients (Pts) With Untreated Non-Germinal Center B-Cell-like (Non-GCB) Subtype Diffuse Large Cell Lymphoma (DLBCL): Results From the Pyramid Trial (NCT00931918).

Authors: 
Journal:  Clin Adv Hematol Oncol       Date:  2016-02

9.  Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Authors:  Nathalie A Johnson; Graham W Slack; Kerry J Savage; Joseph M Connors; Susana Ben-Neriah; Sanja Rogic; David W Scott; King L Tan; Christian Steidl; Laurie H Sehn; Wing C Chan; Javeed Iqbal; Paul N Meyer; Georg Lenz; George Wright; Lisa M Rimsza; Carlo Valentino; Patrick Brunhoeber; Thomas M Grogan; Rita M Braziel; James R Cook; Raymond R Tubbs; Dennis D Weisenburger; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Christina Holcroft; Elaine S Jaffe; Louis M Staudt; Randy D Gascoyne
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

10.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Authors:  Laura Pasqualucci; David Dominguez-Sola; Annalisa Chiarenza; Giulia Fabbri; Adina Grunn; Vladimir Trifonov; Lawryn H Kasper; Stephanie Lerach; Hongyan Tang; Jing Ma; Davide Rossi; Amy Chadburn; Vundavalli V Murty; Charles G Mullighan; Gianluca Gaidano; Raul Rabadan; Paul K Brindle; Riccardo Dalla-Favera
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962
View more
  9 in total

1.  Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.

Authors:  C P Reinert; B Federmann; J Hofmann; H Bösmüller; S Wirths; J Fritz; M Horger
Journal:  Eur Radiol       Date:  2019-06-24       Impact factor: 5.315

2.  Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM.

Authors:  Jun Wang; Yuting Yan; Wenjie Xiong; Ge Song; Yi Wang; Jiawei Zhao; Yujiao Jia; Chengwen Li; Zhen Yu; Ying Yu; Jiawen Chen; Yang Jiao; Tingyu Wang; Rui Lyu; Qinghua Li; Yueshen Ma; Wei Liu; Dehui Zou; Gang An; Qi Sun; Huijun Wang; Zhijian Xiao; Jianxiang Wang; Lugui Qiu; Shuhua Yi
Journal:  Blood Adv       Date:  2022-07-12

3.  Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas.

Authors:  María García-Álvarez; Sara Alonso-Álvarez; Isabel Prieto-Conde; Cristina Jiménez; M Eugenia Sarasquete; M Carmen Chillón; Alejandro Medina; Ana Balanzategui; Rebeca Maldonado; Alicia Antón; Noemí Puig; Marta Rodríguez; Oscar Blanco; Pilar Tamayo; Verónica González-Calle; Alejandro Martín; Ramón García-Sanz; Marcos González; M Dolores Caballero; Miguel Alcoceba
Journal:  Blood Cancer J       Date:  2019-06-17       Impact factor: 11.037

Review 4.  Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) in the Elderly and the Importance of Sport Activity Training.

Authors:  Antonello Sica; Paola Vitiello; Andrea Ronchi; Beniamino Casale; Armando Calogero; Evangelista Sagnelli; Gilca Costa Nachtigal; Teresa Troiani; Renato Franco; Giuseppe Argenziano; Elvira Moscarella; Caterina Sagnelli
Journal:  Int J Environ Res Public Health       Date:  2020-01-29       Impact factor: 3.390

Review 5.  Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma.

Authors:  Eleonora Calabretta; Francesco d'Amore; Carmelo Carlo-Stella
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

Review 6.  Approach to Peribronchovascular Disease on CT.

Authors:  Jane P Ko; Francis Girvin; William Moore; David P Naidich
Journal:  Semin Ultrasound CT MR       Date:  2018-12-20       Impact factor: 1.875

7.  Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma.

Authors:  Wen-Xing Li; Shao-Xing Dai; San-Qi An; Tingting Sun; Justin Liu; Jun Wang; Leyna G Liu; Yang Xun; Hua Yang; Li-Xia Fan; Xiao-Li Zhang; Wan-Qin Liao; Hua You; Luca Tamagnone; Fang Liu; Jing-Fei Huang; Dahai Liu
Journal:  Aging (Albany NY)       Date:  2021-04-22       Impact factor: 5.682

Review 8.  Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma.

Authors:  Xiao-Jie Liang; Xin-Yu Song; Jia-Lin Wu; Dan Liu; Bing-Yu Lin; Hong-Sheng Zhou; Liang Wang
Journal:  Int J Biol Sci       Date:  2022-01-09       Impact factor: 6.580

9.  Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia.

Authors:  Jun Hee Lim; James Q Wang; Fiona Webb; Kartik Saxena; Daniel Enosi Tuipulotu; Abhimanu Pandey; Si Ming Man; Dipti Talaulikar
Journal:  iScience       Date:  2022-08-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.